Meccellis Biotech specializes in tissue and cell engineering.
Meccellis Biotech has raised $8.3M in total funding. The most recent round was Series B. The last funding was announced in November 2022.
Meccellis Biotech's investors include Bpifrance, Credit Agricole CIB, OCEAN PARTICIPATIONS, Banque Populaire Group, Région Nouvelle-Aquitaine.
Meccellis Biotech is headquartered in La Rochelle, France.
Meccellis Biotech specializes in tissue and cell engineering.
Meccellis Biotech is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Meccellis Biotech — Funding & Investors." VCBacked, November 29, 2022, https://www.vcbacked.co/company/meccellis-biotech. Accessed August 14, 2026.
VCBacked. (2022). Meccellis Biotech — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/meccellis-biotech
{{cite web |title=Meccellis Biotech — Funding & Investors |url=https://www.vcbacked.co/company/meccellis-biotech |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated